Circulating Levels of Visceral Adipose Tissue-Derived Serine Protease Inhibitor (Vaspin) Appear as a Marker of Musculoskeletal Pain Disability

Musculoskeletal pain (MSP), specifically low back pain (LBP), is often associated with several adipose tissue-derived cytokines (adipokines) and body composition, but their correlations with the LBP-related disability/severity phenotypes remain poorly understood. In this cross-sectional study, two s...

Full description

Bibliographic Details
Main Authors: Nader Tarabeih, Alexander Kalinkovich, Adel Shalata, Gregory Livshits
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/10/10/797
_version_ 1827704784204857344
author Nader Tarabeih
Alexander Kalinkovich
Adel Shalata
Gregory Livshits
author_facet Nader Tarabeih
Alexander Kalinkovich
Adel Shalata
Gregory Livshits
author_sort Nader Tarabeih
collection DOAJ
description Musculoskeletal pain (MSP), specifically low back pain (LBP), is often associated with several adipose tissue-derived cytokines (adipokines) and body composition, but their correlations with the LBP-related disability/severity phenotypes remain poorly understood. In this cross-sectional study, two self-reported validated questionnaires were used to collect back pain and disability data in an ethnically homogeneous family-based population sample (<i>N</i> = 1078). Plasma levels of relatively new adipokines, vaspin and adipsin, were detected by ELISA. Body composition parameters, including fat, skeletal muscle mass, extracellular water (ECW), and others were assessed through bioelectrical impedance analysis (BIA) technology. Statistical analysis was conducted, accounting for the familial composition of the sample. The multiple regression analyses with four LBP-related phenotypes as dependent variables consistently showed, for the first time, the significant associations with vaspin levels, regardless of other covariates. The odds ratios (OR)/SD ranged between 1.24 (95%CI = 1.03–1.50) and 1.33 (95%CI = 1.07–1.64), depending on the LBP phenotype. Among the tested body composition covariates, only ECW levels displayed consistent and highly significant associations with all tested LBP phenotypes (OR from 1.43, 95%CI = 1.14–1.79 to 1.68, 95%CI = 1.26–2.24). The results clearly suggest that circulating concentrations of vaspin and ECW levels could serve as biomarkers of MSP/LBP severity and complications.
first_indexed 2024-03-10T15:48:02Z
format Article
id doaj.art-abcda74ca0104ca086e2837de1cabbe8
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-03-10T15:48:02Z
publishDate 2020-10-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-abcda74ca0104ca086e2837de1cabbe82023-11-20T16:20:11ZengMDPI AGDiagnostics2075-44182020-10-01101079710.3390/diagnostics10100797Circulating Levels of Visceral Adipose Tissue-Derived Serine Protease Inhibitor (Vaspin) Appear as a Marker of Musculoskeletal Pain DisabilityNader Tarabeih0Alexander Kalinkovich1Adel Shalata2Gregory Livshits3Department of Anatomy and Anthropology, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 6905126, IsraelDepartment of Anatomy and Anthropology, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 6905126, IsraelThe Simon Winter Institute for Human Genetics, Bnai Zion Medical Center, The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa 32000, IsraelDepartment of Anatomy and Anthropology, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 6905126, IsraelMusculoskeletal pain (MSP), specifically low back pain (LBP), is often associated with several adipose tissue-derived cytokines (adipokines) and body composition, but their correlations with the LBP-related disability/severity phenotypes remain poorly understood. In this cross-sectional study, two self-reported validated questionnaires were used to collect back pain and disability data in an ethnically homogeneous family-based population sample (<i>N</i> = 1078). Plasma levels of relatively new adipokines, vaspin and adipsin, were detected by ELISA. Body composition parameters, including fat, skeletal muscle mass, extracellular water (ECW), and others were assessed through bioelectrical impedance analysis (BIA) technology. Statistical analysis was conducted, accounting for the familial composition of the sample. The multiple regression analyses with four LBP-related phenotypes as dependent variables consistently showed, for the first time, the significant associations with vaspin levels, regardless of other covariates. The odds ratios (OR)/SD ranged between 1.24 (95%CI = 1.03–1.50) and 1.33 (95%CI = 1.07–1.64), depending on the LBP phenotype. Among the tested body composition covariates, only ECW levels displayed consistent and highly significant associations with all tested LBP phenotypes (OR from 1.43, 95%CI = 1.14–1.79 to 1.68, 95%CI = 1.26–2.24). The results clearly suggest that circulating concentrations of vaspin and ECW levels could serve as biomarkers of MSP/LBP severity and complications.https://www.mdpi.com/2075-4418/10/10/797low back paindisabilitybody compositionvaspinextracellular water
spellingShingle Nader Tarabeih
Alexander Kalinkovich
Adel Shalata
Gregory Livshits
Circulating Levels of Visceral Adipose Tissue-Derived Serine Protease Inhibitor (Vaspin) Appear as a Marker of Musculoskeletal Pain Disability
Diagnostics
low back pain
disability
body composition
vaspin
extracellular water
title Circulating Levels of Visceral Adipose Tissue-Derived Serine Protease Inhibitor (Vaspin) Appear as a Marker of Musculoskeletal Pain Disability
title_full Circulating Levels of Visceral Adipose Tissue-Derived Serine Protease Inhibitor (Vaspin) Appear as a Marker of Musculoskeletal Pain Disability
title_fullStr Circulating Levels of Visceral Adipose Tissue-Derived Serine Protease Inhibitor (Vaspin) Appear as a Marker of Musculoskeletal Pain Disability
title_full_unstemmed Circulating Levels of Visceral Adipose Tissue-Derived Serine Protease Inhibitor (Vaspin) Appear as a Marker of Musculoskeletal Pain Disability
title_short Circulating Levels of Visceral Adipose Tissue-Derived Serine Protease Inhibitor (Vaspin) Appear as a Marker of Musculoskeletal Pain Disability
title_sort circulating levels of visceral adipose tissue derived serine protease inhibitor vaspin appear as a marker of musculoskeletal pain disability
topic low back pain
disability
body composition
vaspin
extracellular water
url https://www.mdpi.com/2075-4418/10/10/797
work_keys_str_mv AT nadertarabeih circulatinglevelsofvisceraladiposetissuederivedserineproteaseinhibitorvaspinappearasamarkerofmusculoskeletalpaindisability
AT alexanderkalinkovich circulatinglevelsofvisceraladiposetissuederivedserineproteaseinhibitorvaspinappearasamarkerofmusculoskeletalpaindisability
AT adelshalata circulatinglevelsofvisceraladiposetissuederivedserineproteaseinhibitorvaspinappearasamarkerofmusculoskeletalpaindisability
AT gregorylivshits circulatinglevelsofvisceraladiposetissuederivedserineproteaseinhibitorvaspinappearasamarkerofmusculoskeletalpaindisability